UK markets open in 3 hours 33 minutes
NIKKEI 225
38,243.59 +14.48 (+0.04%) HANG SENG
19,017.08 +53.40 (+0.28%) CRUDE OIL
78.05 -0.21 (-0.27%) GOLD FUTURES
2,363.30 -11.70 (-0.49%) DOW
39,512.84 +837.14 (+2.16%) Bitcoin GBP
48,588.51 -31.03 (-0.06%)
GILD Jan 2025 80.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:02AM EDT. Market open.
| Previous close | 0.8800 |
| Open | 1.1600 |
| Bid | 1.1200 |
| Ask | 1.2000 |
| Strike | 80.00 |
| Expiry date | 2025-01-17 |
| Day's range | 1.1600 - 1.1800 |
| Contract range | N/A |
| Volume | |
| Open interest | 3.06k |
ZacksGilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Gilead (GILD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Business WireKite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
REDWOOD CITY, Calif. & SANTA MONICA, Calif., May 09, 2024--Kite, a Gilead Company (NASDAQ: GILD), and Arcellx, Inc. (NASDAQ: ACLX) today announced several key operational updates on their partnered anitocabtagene autoleucel (anito-cel) multiple myeloma program. Anito-cel is the first BCMA CAR T to be investigated in multiple myeloma that utilizes Arcellx’s novel and compact D-Domain binder.
GuruFocus.comDecoding Gilead Sciences Inc (GILD): A Strategic SWOT Insight
Unraveling the Financial Dynamics and Strategic Directions of Gilead Sciences Inc (GILD)
© 2024 Yahoo. All rights reserved.